A carregar...

Clinical Symptoms and Microbiological Outcomes in Tuberculosis Treatment Trials

During a recent Food and Drug Administration workshop on clinical trials to evaluate new TB drugs, questions were raised regarding the use of bacteriologic endpoints such as treatment failure and relapse as measures of improvement in health status and long term outcome after treatment. FDA scientist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bark, C.M., Dietze, R., Okwera, A., Quelapio, M.I., Thiel, B.A., Johnson, J.L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3215825/
https://ncbi.nlm.nih.gov/pubmed/21813327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tube.2011.05.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!